Posted inInternal Medicine Neurology news
Integrating Plasma p-tau217 and APOE Genotype to Predict Cognitive Decline Across Diverse Populations
This pooled analysis of seven multi-ethnic cohorts demonstrates the combined prognostic value of plasma phosphorylated tau 217 concentrations and APOE-ε4 genotype for predicting risk and timing of cognitive impairment, emphasizing biomarker-guided strategies prior to symptom onset.
